Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05396586 · ClinicalTrials.gov registry record · NA

Understanding Individual Differences in Working Memory Training and Transfer in Older Adults

A NA study, sponsored by Northeastern University.

Completed
Registry status
NA
Development phase
313
Enrollment target

NCT05396586: Completed NA study, sponsored by Northeastern University.

NCT05396586 is a NA study that has completed, run by Northeastern University. The registered enrollment target is 313 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05396586, a NA study, has completed, sponsored by Northeastern University.

COMPLETED
Registry status
NA
Development phase
313 participants
Enrollment target

Study Summary

The present study investigates how individual differences in cognitive processing contribute to the efficacy of working memory training programs in an older adult population. In a randomized crossover design, different types of working memory training interventions will be evaluated within the same participants. Adding game-like elements to working memory training programs can increase motivation and engagement, which can increase learning. However this process, termed gamification, adds sensory complexity that can lead to increased mental load and/or distraction in older adults. Investigators hypothesize that gamification of training tasks will be beneficial to some and counterproductive to other participants. The investigators will test two models; the first assumes that participants with difficulty inhibiting distracting information will show better learning and transfer when assigned to non-gamified training, whereas those with more distractor tolerance will show better learning and transfer when assigned to gamified training. The second model states that the outcomes of the intervention will be better predicted by performance on measures of general cognitive ability. In a separate study, the investigators will compare working memory training that contains rich, multisensory information with a training program that contains only visual information. Here they will also test two models; the first assumes that participants with difficulty binding two stimulus streams will show better learning and transfer when assigned to visual-only working memory training, whereas participants who do not have this difficulty will show better learning and transfer when assigned to multisensory working memory training. The second model states that the outcomes of the intervention will be better predicted by performance on measures of general cognitive ability.

Primary Outcome

N-back is a tablet-based updating working memory task. Participants see a consecutive stream of pictures and are asked to tap the pictures that match those presented N items earlier. All participants will complete 1-back and 2-back, progression to 3-back and beyond is based on performance on the previous level (no more than 4 errors). The outcome measure is the change in the highest N-level reached on the task compared to baseline at Day 2.

Interventions

  • BEHAVIORAL Span
  • BEHAVIORAL N-back
  • BEHAVIORAL Multisensory

Trial Details

FieldValue
Enrollment Target 313 participants
Start Date 2022-03-17
Est. Completion 2025-03-05
Phase NA
Northeastern University

39 total trials

What the finished NCT05396586 record still lists

NCT05396586 is an interventional study that assigns participants to a tested intervention. The registered 313 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 3 interventions - of which Span is the first listed.

NCT05396586 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05396586 about?

NCT05396586 is a clinical study titled "Understanding Individual Differences in Working Memory Training and Transfer in Older Adults". The present study investigates how individual differences in cognitive processing contribute to the efficacy of working memory training programs in an older adult population. In a randomized crossover design, different types of working memory training interventions will be evaluated within the same ...

What is the current status of trial NCT05396586?

This trial is currently completed. It is a NA study. The enrollment target is 313 participants. The study started on 2022-03-17. Estimated completion is 2025-03-05.

What interventions are being tested in trial NCT05396586?

The interventions under investigation include: Span (BEHAVIORAL), N-back (BEHAVIORAL), Multisensory (BEHAVIORAL).

Who is sponsoring clinical trial NCT05396586?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05396586's enrollment target sits among peer trials

313 323rd of 2000 higher than 1,678 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00595491 · 313 participants · Phase 1

    Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation

  • NCT03866382 · 314 participants · Phase 2

    Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • NCT04500756 · 314 participants · Phase 2

    Limiting AAA With Metformin (LIMIT) Trial

  • NCT06167746 · 314 participants · Phase 3

    iCare4Me Transitions

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05396586, the US trial registry maintained by the National Library of Medicine. NCT05396586 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.